{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Indiana",
      "state": "PA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "76457",
      "recalling_firm": "RemedyRepack Inc.",
      "address_1": "625 Kolter Dr Ste 4",
      "address_2": "N/A",
      "postal_code": "15701-3571",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed to  a sold customer in FL.",
      "recall_number": "D-0482-2017",
      "product_description": "Glipizide 2.5 mg ER Tablets, Manufactured by Watson Laboratories, Inc., Parsippany, NJ 07054, Repackaged by RemedyRepack, Indiana, PA 15701, NDC 52125-0764-02",
      "product_quantity": "630 pills (21 bottles x 30 pills per HDPE bottle)",
      "reason_for_recall": "Failed Dissolution Specifications",
      "recall_initiation_date": "20170207",
      "center_classification_date": "20170218",
      "termination_date": "20170505",
      "report_date": "20170301",
      "code_info": "Lot #  B0129373-021916; Exp. 10/17    00591-0900-30  Original NDC  52125-0764-02  RemedyRepack NDC"
    }
  ]
}